nodes	percent_of_prediction	percent_of_DWPC	metapath
Pazopanib—ABCG2—Glyburide—gestational diabetes	0.223	0.634	CbGbCtD
Pazopanib—ABCB1—Glyburide—gestational diabetes	0.0805	0.229	CbGbCtD
Pazopanib—CYP3A4—Glyburide—gestational diabetes	0.0482	0.137	CbGbCtD
Pazopanib—FLT1—umbilical vein—gestational diabetes	0.0124	0.0371	CbGeAlD
Pazopanib—KDR—umbilical vein—gestational diabetes	0.0105	0.0314	CbGeAlD
Pazopanib—MAP3K9—islet of Langerhans—gestational diabetes	0.00932	0.0279	CbGeAlD
Pazopanib—SH2B3—islet of Langerhans—gestational diabetes	0.00659	0.0197	CbGeAlD
Pazopanib—STK16—islet of Langerhans—gestational diabetes	0.0056	0.0168	CbGeAlD
Pazopanib—FGFR3—embryo—gestational diabetes	0.00533	0.016	CbGeAlD
Pazopanib—MAP3K9—vagina—gestational diabetes	0.00494	0.0148	CbGeAlD
Pazopanib—ITK—adipose tissue—gestational diabetes	0.0049	0.0147	CbGeAlD
Pazopanib—PI4KB—islet of Langerhans—gestational diabetes	0.00488	0.0146	CbGeAlD
Pazopanib—MAP3K9—head—gestational diabetes	0.00456	0.0137	CbGeAlD
Pazopanib—TAOK1—uterus—gestational diabetes	0.00456	0.0137	CbGeAlD
Pazopanib—Encephalopathy—Glyburide—gestational diabetes	0.00452	0.0887	CcSEcCtD
Pazopanib—TAOK1—adipose tissue—gestational diabetes	0.00446	0.0134	CbGeAlD
Pazopanib—SH2B3—uterus—gestational diabetes	0.0043	0.0129	CbGeAlD
Pazopanib—PIP4K2C—islet of Langerhans—gestational diabetes	0.00428	0.0128	CbGeAlD
Pazopanib—SH2B3—adipose tissue—gestational diabetes	0.0042	0.0126	CbGeAlD
Pazopanib—FLT4—embryo—gestational diabetes	0.00416	0.0125	CbGeAlD
Pazopanib—ITK—vagina—gestational diabetes	0.00407	0.0122	CbGeAlD
Pazopanib—TAOK1—vagina—gestational diabetes	0.00371	0.0111	CbGeAlD
Pazopanib—FGF1—embryo—gestational diabetes	0.0037	0.0111	CbGeAlD
Pazopanib—STK16—adipose tissue—gestational diabetes	0.00357	0.0107	CbGeAlD
Pazopanib—BMPR1B—uterus—gestational diabetes	0.00356	0.0107	CbGeAlD
Pazopanib—RIOK2—adipose tissue—gestational diabetes	0.00352	0.0105	CbGeAlD
Pazopanib—SH2B3—vagina—gestational diabetes	0.00349	0.0105	CbGeAlD
Pazopanib—FGFR2—embryo—gestational diabetes	0.00349	0.0105	CbGeAlD
Pazopanib—BMPR1B—adipose tissue—gestational diabetes	0.00348	0.0104	CbGeAlD
Pazopanib—TAOK1—head—gestational diabetes	0.00343	0.0103	CbGeAlD
Pazopanib—FLT1—islet of Langerhans—gestational diabetes	0.00335	0.01	CbGeAlD
Pazopanib—EPHB6—islet of Langerhans—gestational diabetes	0.00331	0.0099	CbGeAlD
Pazopanib—FLT1—embryo—gestational diabetes	0.00324	0.00969	CbGeAlD
Pazopanib—SH2B3—head—gestational diabetes	0.00323	0.00966	CbGeAlD
Pazopanib—Hyperbilirubinaemia—Glyburide—gestational diabetes	0.00319	0.0626	CcSEcCtD
Pazopanib—PI4KB—uterus—gestational diabetes	0.00318	0.00952	CbGeAlD
Pazopanib—AURKC—head—gestational diabetes	0.00318	0.00951	CbGeAlD
Pazopanib—STK36—adipose tissue—gestational diabetes	0.00316	0.00946	CbGeAlD
Pazopanib—TAOK3—islet of Langerhans—gestational diabetes	0.00315	0.00945	CbGeAlD
Pazopanib—LIMK2—uterus—gestational diabetes	0.00312	0.00935	CbGeAlD
Pazopanib—PI4KB—adipose tissue—gestational diabetes	0.00311	0.00931	CbGeAlD
Pazopanib—LIMK2—adipose tissue—gestational diabetes	0.00305	0.00914	CbGeAlD
Pazopanib—PDGFRA—embryo—gestational diabetes	0.00303	0.00908	CbGeAlD
Pazopanib—STK16—vagina—gestational diabetes	0.00297	0.00889	CbGeAlD
Pazopanib—RIOK2—vagina—gestational diabetes	0.00292	0.00875	CbGeAlD
Pazopanib—FGFR1—uterus—gestational diabetes	0.00277	0.00829	CbGeAlD
Pazopanib—FLT4—adipose tissue—gestational diabetes	0.00274	0.00822	CbGeAlD
Pazopanib—STK16—head—gestational diabetes	0.00274	0.00821	CbGeAlD
Pazopanib—KDR—embryo—gestational diabetes	0.00273	0.00819	CbGeAlD
Pazopanib—PIP4K2C—adipose tissue—gestational diabetes	0.00273	0.00817	CbGeAlD
Pazopanib—LYN—head—gestational diabetes	0.00271	0.00813	CbGeAlD
Pazopanib—FGFR1—adipose tissue—gestational diabetes	0.00271	0.00811	CbGeAlD
Pazopanib—FGFR3—head—gestational diabetes	0.0027	0.00809	CbGeAlD
Pazopanib—RIOK2—head—gestational diabetes	0.0027	0.00809	CbGeAlD
Pazopanib—MAP3K19—head—gestational diabetes	0.00267	0.008	CbGeAlD
Pazopanib—BMPR1B—head—gestational diabetes	0.00267	0.008	CbGeAlD
Pazopanib—CSF1R—embryo—gestational diabetes	0.00267	0.00799	CbGeAlD
Pazopanib—MAP3K2—uterus—gestational diabetes	0.00265	0.00792	CbGeAlD
Pazopanib—STK36—vagina—gestational diabetes	0.00263	0.00786	CbGeAlD
Pazopanib—MAP3K2—adipose tissue—gestational diabetes	0.00259	0.00775	CbGeAlD
Pazopanib—PI4KB—vagina—gestational diabetes	0.00259	0.00774	CbGeAlD
Pazopanib—LIMK2—vagina—gestational diabetes	0.00254	0.0076	CbGeAlD
Pazopanib—LCK—uterus—gestational diabetes	0.00248	0.00742	CbGeAlD
Pazopanib—PDGFRB—islet of Langerhans—gestational diabetes	0.00245	0.00733	CbGeAlD
Pazopanib—FGF1—adipose tissue—gestational diabetes	0.00244	0.0073	CbGeAlD
Pazopanib—STK36—head—gestational diabetes	0.00243	0.00726	CbGeAlD
Pazopanib—KIT—embryo—gestational diabetes	0.00242	0.00726	CbGeAlD
Pazopanib—LCK—adipose tissue—gestational diabetes	0.00242	0.00725	CbGeAlD
Pazopanib—Hepatic function abnormal—Glyburide—gestational diabetes	0.00241	0.0473	CcSEcCtD
Pazopanib—PI4KB—head—gestational diabetes	0.00239	0.00715	CbGeAlD
Pazopanib—PDGFRB—embryo—gestational diabetes	0.00237	0.00709	CbGeAlD
Pazopanib—FGFR2—uterus—gestational diabetes	0.00235	0.00705	CbGeAlD
Pazopanib—LIMK2—head—gestational diabetes	0.00234	0.00702	CbGeAlD
Pazopanib—Hepatic failure—Glyburide—gestational diabetes	0.00234	0.046	CcSEcCtD
Pazopanib—FGFR2—adipose tissue—gestational diabetes	0.0023	0.00689	CbGeAlD
Pazopanib—PIP4K2C—vagina—gestational diabetes	0.00227	0.00679	CbGeAlD
Pazopanib—FGFR1—vagina—gestational diabetes	0.00225	0.00674	CbGeAlD
Pazopanib—FLT1—uterus—gestational diabetes	0.00218	0.00653	CbGeAlD
Pazopanib—FLT1—adipose tissue—gestational diabetes	0.00213	0.00639	CbGeAlD
Pazopanib—Hyponatraemia—Glyburide—gestational diabetes	0.00212	0.0415	CcSEcCtD
Pazopanib—EPHB6—adipose tissue—gestational diabetes	0.00211	0.00631	CbGeAlD
Pazopanib—FLT4—head—gestational diabetes	0.00211	0.00631	CbGeAlD
Pazopanib—PIP4K2C—head—gestational diabetes	0.0021	0.00627	CbGeAlD
Pazopanib—STK10—uterus—gestational diabetes	0.00206	0.00618	CbGeAlD
Pazopanib—TAOK3—uterus—gestational diabetes	0.00206	0.00616	CbGeAlD
Pazopanib—PDGFRA—uterus—gestational diabetes	0.00204	0.00612	CbGeAlD
Pazopanib—STK10—adipose tissue—gestational diabetes	0.00202	0.00605	CbGeAlD
Pazopanib—LCK—vagina—gestational diabetes	0.00201	0.00603	CbGeAlD
Pazopanib—TAOK3—adipose tissue—gestational diabetes	0.00201	0.00602	CbGeAlD
Pazopanib—PDGFRA—adipose tissue—gestational diabetes	0.002	0.00599	CbGeAlD
Pazopanib—MAP3K2—head—gestational diabetes	0.00199	0.00595	CbGeAlD
Pazopanib—FGF1—head—gestational diabetes	0.00187	0.0056	CbGeAlD
Pazopanib—KDR—uterus—gestational diabetes	0.00184	0.00552	CbGeAlD
Pazopanib—Abdominal distension—Glyburide—gestational diabetes	0.00183	0.036	CcSEcCtD
Pazopanib—KDR—adipose tissue—gestational diabetes	0.0018	0.0054	CbGeAlD
Pazopanib—MAP2K5—adipose tissue—gestational diabetes	0.0018	0.0054	CbGeAlD
Pazopanib—CSF1R—uterus—gestational diabetes	0.0018	0.00539	CbGeAlD
Pazopanib—Pancreatitis—Glyburide—gestational diabetes	0.00179	0.035	CcSEcCtD
Pazopanib—FLT1—vagina—gestational diabetes	0.00177	0.00531	CbGeAlD
Pazopanib—FGFR2—head—gestational diabetes	0.00177	0.00529	CbGeAlD
Pazopanib—CSF1R—adipose tissue—gestational diabetes	0.00176	0.00527	CbGeAlD
Pazopanib—EPHB6—vagina—gestational diabetes	0.00175	0.00525	CbGeAlD
Pazopanib—STK10—vagina—gestational diabetes	0.00168	0.00503	CbGeAlD
Pazopanib—TAOK3—vagina—gestational diabetes	0.00167	0.00501	CbGeAlD
Pazopanib—Photosensitivity reaction—Glyburide—gestational diabetes	0.00166	0.0326	CcSEcCtD
Pazopanib—PDGFRA—vagina—gestational diabetes	0.00166	0.00498	CbGeAlD
Pazopanib—FLT1—head—gestational diabetes	0.00164	0.00491	CbGeAlD
Pazopanib—KIT—uterus—gestational diabetes	0.00163	0.00489	CbGeAlD
Pazopanib—EPHB6—head—gestational diabetes	0.00162	0.00485	CbGeAlD
Pazopanib—KIT—adipose tissue—gestational diabetes	0.0016	0.00479	CbGeAlD
Pazopanib—PDGFRB—uterus—gestational diabetes	0.0016	0.00478	CbGeAlD
Pazopanib—Jaundice—Glyburide—gestational diabetes	0.00158	0.0311	CcSEcCtD
Pazopanib—PDGFRB—adipose tissue—gestational diabetes	0.00156	0.00467	CbGeAlD
Pazopanib—STK10—head—gestational diabetes	0.00155	0.00464	CbGeAlD
Pazopanib—TAOK3—head—gestational diabetes	0.00154	0.00463	CbGeAlD
Pazopanib—PDGFRA—head—gestational diabetes	0.00154	0.0046	CbGeAlD
Pazopanib—MAP2K5—vagina—gestational diabetes	0.0015	0.00449	CbGeAlD
Pazopanib—KDR—vagina—gestational diabetes	0.0015	0.00449	CbGeAlD
Pazopanib—CSF1R—vagina—gestational diabetes	0.00146	0.00438	CbGeAlD
Pazopanib—KDR—head—gestational diabetes	0.00138	0.00415	CbGeAlD
Pazopanib—MAP2K5—head—gestational diabetes	0.00138	0.00415	CbGeAlD
Pazopanib—Eye disorder—Glyburide—gestational diabetes	0.00136	0.0267	CcSEcCtD
Pazopanib—CSF1R—head—gestational diabetes	0.00135	0.00405	CbGeAlD
Pazopanib—KIT—vagina—gestational diabetes	0.00133	0.00398	CbGeAlD
Pazopanib—PDGFRB—vagina—gestational diabetes	0.0013	0.00389	CbGeAlD
Pazopanib—Alopecia—Glyburide—gestational diabetes	0.00129	0.0253	CcSEcCtD
Pazopanib—Malnutrition—Glyburide—gestational diabetes	0.00127	0.0249	CcSEcCtD
Pazopanib—Erythema—Glyburide—gestational diabetes	0.00127	0.0249	CcSEcCtD
Pazopanib—KIT—head—gestational diabetes	0.00123	0.00367	CbGeAlD
Pazopanib—PDGFRB—head—gestational diabetes	0.0012	0.00359	CbGeAlD
Pazopanib—Vision blurred—Glyburide—gestational diabetes	0.0012	0.0235	CcSEcCtD
Pazopanib—Anaemia—Glyburide—gestational diabetes	0.00117	0.023	CcSEcCtD
Pazopanib—Leukopenia—Glyburide—gestational diabetes	0.00114	0.0223	CcSEcCtD
Pazopanib—Arthralgia—Glyburide—gestational diabetes	0.00108	0.0212	CcSEcCtD
Pazopanib—Myalgia—Glyburide—gestational diabetes	0.00108	0.0212	CcSEcCtD
Pazopanib—Oedema—Glyburide—gestational diabetes	0.00104	0.0203	CcSEcCtD
Pazopanib—Shock—Glyburide—gestational diabetes	0.00102	0.02	CcSEcCtD
Pazopanib—Nervous system disorder—Glyburide—gestational diabetes	0.00102	0.0199	CcSEcCtD
Pazopanib—Thrombocytopenia—Glyburide—gestational diabetes	0.00101	0.0199	CcSEcCtD
Pazopanib—Hyperhidrosis—Glyburide—gestational diabetes	0.001	0.0196	CcSEcCtD
Pazopanib—Anorexia—Glyburide—gestational diabetes	0.000987	0.0194	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Glyburide—gestational diabetes	0.000943	0.0185	CcSEcCtD
Pazopanib—Paraesthesia—Glyburide—gestational diabetes	0.00093	0.0182	CcSEcCtD
Pazopanib—Dyspnoea—Glyburide—gestational diabetes	0.000923	0.0181	CcSEcCtD
Pazopanib—Dyspepsia—Glyburide—gestational diabetes	0.000912	0.0179	CcSEcCtD
Pazopanib—Decreased appetite—Glyburide—gestational diabetes	0.0009	0.0177	CcSEcCtD
Pazopanib—ABCG2—uterus—gestational diabetes	0.000897	0.00269	CbGeAlD
Pazopanib—Gastrointestinal disorder—Glyburide—gestational diabetes	0.000894	0.0175	CcSEcCtD
Pazopanib—ABCG2—adipose tissue—gestational diabetes	0.000877	0.00263	CbGeAlD
Pazopanib—Gastrointestinal pain—Glyburide—gestational diabetes	0.000847	0.0166	CcSEcCtD
Pazopanib—Abdominal pain—Glyburide—gestational diabetes	0.000819	0.0161	CcSEcCtD
Pazopanib—CYP2C8—vagina—gestational diabetes	0.00075	0.00225	CbGeAlD
Pazopanib—Asthenia—Glyburide—gestational diabetes	0.000743	0.0146	CcSEcCtD
Pazopanib—Pruritus—Glyburide—gestational diabetes	0.000733	0.0144	CcSEcCtD
Pazopanib—ABCG2—vagina—gestational diabetes	0.000729	0.00218	CbGeAlD
Pazopanib—Diarrhoea—Glyburide—gestational diabetes	0.000709	0.0139	CcSEcCtD
Pazopanib—ABCB1—islet of Langerhans—gestational diabetes	0.000678	0.00203	CbGeAlD
Pazopanib—Vomiting—Glyburide—gestational diabetes	0.000658	0.0129	CcSEcCtD
Pazopanib—ABCB1—embryo—gestational diabetes	0.000656	0.00196	CbGeAlD
Pazopanib—Rash—Glyburide—gestational diabetes	0.000653	0.0128	CcSEcCtD
Pazopanib—Dermatitis—Glyburide—gestational diabetes	0.000652	0.0128	CcSEcCtD
Pazopanib—Headache—Glyburide—gestational diabetes	0.000649	0.0127	CcSEcCtD
Pazopanib—Nausea—Glyburide—gestational diabetes	0.000615	0.0121	CcSEcCtD
Pazopanib—CYP2D6—head—gestational diabetes	0.000462	0.00138	CbGeAlD
Pazopanib—ABCB1—uterus—gestational diabetes	0.000442	0.00132	CbGeAlD
Pazopanib—ABCB1—adipose tissue—gestational diabetes	0.000433	0.0013	CbGeAlD
Pazopanib—ABCB1—vagina—gestational diabetes	0.00036	0.00108	CbGeAlD
Pazopanib—ABCB1—head—gestational diabetes	0.000332	0.000995	CbGeAlD
Pazopanib—FGFR1—Developmental Biology—ADIPOQ—gestational diabetes	0.000239	0.000909	CbGpPWpGaD
Pazopanib—FGFR1—B Cell Activation—FGF2—gestational diabetes	0.000237	0.000902	CbGpPWpGaD
Pazopanib—PDGFRA—B Cell Activation—FGF2—gestational diabetes	0.000237	0.0009	CbGpPWpGaD
Pazopanib—PDGFRB—Fc epsilon receptor (FCERI) signaling—FGF2—gestational diabetes	0.000231	0.000876	CbGpPWpGaD
Pazopanib—PDGFRB—DAP12 interactions—FGF2—gestational diabetes	0.000231	0.000876	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling by FGFR in disease—FGF2—gestational diabetes	0.000231	0.000876	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling by EGFR—FGF2—gestational diabetes	0.000228	0.000868	CbGpPWpGaD
Pazopanib—FGFR1—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.000227	0.000864	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—MTNR1B—gestational diabetes	0.000227	0.000863	CbGpPWpGaD
Pazopanib—MAP2K5—MAPK Signaling Pathway—TNF—gestational diabetes	0.000227	0.000863	CbGpPWpGaD
Pazopanib—PDGFRA—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.000227	0.000861	CbGpPWpGaD
Pazopanib—FGF1—Signaling by NGF—FGF2—gestational diabetes	0.000227	0.000861	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling by EGFR in Cancer—FGF2—gestational diabetes	0.000226	0.000861	CbGpPWpGaD
Pazopanib—LYN—Fc epsilon receptor (FCERI) signaling—FGF2—gestational diabetes	0.000226	0.000858	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling by PDGF—FGF2—gestational diabetes	0.000225	0.000857	CbGpPWpGaD
Pazopanib—LCK—Signaling by SCF-KIT—FGF2—gestational diabetes	0.000222	0.000843	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—RBP4—gestational diabetes	0.000221	0.000841	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—LEPR—gestational diabetes	0.000219	0.000834	CbGpPWpGaD
Pazopanib—FGFR3—Disease—NAMPT—gestational diabetes	0.000217	0.000823	CbGpPWpGaD
Pazopanib—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000216	0.000822	CbGpPWpGaD
Pazopanib—FGF1—Immune System—MBL2—gestational diabetes	0.000216	0.000819	CbGpPWpGaD
Pazopanib—FGFR3—Disease—GCK—gestational diabetes	0.000215	0.000818	CbGpPWpGaD
Pazopanib—CYP2C8—Biological oxidations—CYP19A1—gestational diabetes	0.000214	0.000814	CbGpPWpGaD
Pazopanib—SH2B3—Signaling Pathways—LEP—gestational diabetes	0.000213	0.000811	CbGpPWpGaD
Pazopanib—PDGFRB—B Cell Activation—FGF2—gestational diabetes	0.000213	0.000811	CbGpPWpGaD
Pazopanib—LCK—Downstream signaling of activated FGFR—FGF2—gestational diabetes	0.000212	0.000807	CbGpPWpGaD
Pazopanib—CYP2C8—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000211	0.000803	CbGpPWpGaD
Pazopanib—LYN—Developmental Biology—ADIPOQ—gestational diabetes	0.00021	0.0008	CbGpPWpGaD
Pazopanib—LCK—Signaling by ERBB4—FGF2—gestational diabetes	0.000209	0.000794	CbGpPWpGaD
Pazopanib—LYN—B Cell Activation—FGF2—gestational diabetes	0.000209	0.000794	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—MBL2—gestational diabetes	0.000206	0.000782	CbGpPWpGaD
Pazopanib—PDGFRB—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.000204	0.000776	CbGpPWpGaD
Pazopanib—KDR—Developmental Biology—LEP—gestational diabetes	0.000202	0.000767	CbGpPWpGaD
Pazopanib—FGF1—Disease—RBP4—gestational diabetes	0.000201	0.000763	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—GGCT—gestational diabetes	0.0002	0.00076	CbGpPWpGaD
Pazopanib—LCK—Downstream signal transduction—FGF2—gestational diabetes	0.0002	0.000758	CbGpPWpGaD
Pazopanib—LCK—Signaling by FGFR—FGF2—gestational diabetes	0.000199	0.000755	CbGpPWpGaD
Pazopanib—LCK—Signaling by ERBB2—FGF2—gestational diabetes	0.000198	0.000751	CbGpPWpGaD
Pazopanib—LCK—DAP12 signaling—FGF2—gestational diabetes	0.000197	0.000747	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—LEPR—gestational diabetes	0.000196	0.000746	CbGpPWpGaD
Pazopanib—LCK—Downstream signaling events of B Cell Receptor (BCR)—FGF2—gestational diabetes	0.000194	0.000737	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—LEPR—gestational diabetes	0.000191	0.000727	CbGpPWpGaD
Pazopanib—FGF1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	0.000191	0.000724	CbGpPWpGaD
Pazopanib—FGFR2—Signaling by NGF—FGF2—gestational diabetes	0.000188	0.000713	CbGpPWpGaD
Pazopanib—SLCO1B1—Transmembrane transport of small molecules—GCK—gestational diabetes	0.000186	0.000707	CbGpPWpGaD
Pazopanib—LCK—DAP12 interactions—FGF2—gestational diabetes	0.000185	0.000703	CbGpPWpGaD
Pazopanib—LCK—Fc epsilon receptor (FCERI) signaling—FGF2—gestational diabetes	0.000185	0.000703	CbGpPWpGaD
Pazopanib—LCK—Signaling by FGFR in disease—FGF2—gestational diabetes	0.000185	0.000703	CbGpPWpGaD
Pazopanib—KIT—Signaling by NGF—FGF2—gestational diabetes	0.000184	0.0007	CbGpPWpGaD
Pazopanib—LCK—Signaling by EGFR—FGF2—gestational diabetes	0.000183	0.000697	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—GGCT—gestational diabetes	0.000183	0.000696	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—LEPR—gestational diabetes	0.000182	0.000693	CbGpPWpGaD
Pazopanib—LCK—Signaling by EGFR in Cancer—FGF2—gestational diabetes	0.000182	0.000691	CbGpPWpGaD
Pazopanib—LCK—Signaling by PDGF—FGF2—gestational diabetes	0.000181	0.000688	CbGpPWpGaD
Pazopanib—FGF1—Disease—NAMPT—gestational diabetes	0.00018	0.000684	CbGpPWpGaD
Pazopanib—FGF1—Disease—GCK—gestational diabetes	0.000179	0.00068	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—MBL2—gestational diabetes	0.000178	0.000678	CbGpPWpGaD
Pazopanib—CYP2D6—Biological oxidations—CYP19A1—gestational diabetes	0.000176	0.000668	CbGpPWpGaD
Pazopanib—KIT—Immune System—MBL2—gestational diabetes	0.000175	0.000666	CbGpPWpGaD
Pazopanib—FGFR1—Signaling by NGF—FGF2—gestational diabetes	0.000175	0.000664	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—GLS2—gestational diabetes	0.000175	0.000664	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling by NGF—FGF2—gestational diabetes	0.000174	0.000662	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—MTNR1B—gestational diabetes	0.000173	0.000659	CbGpPWpGaD
Pazopanib—CYP2D6—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000173	0.000659	CbGpPWpGaD
Pazopanib—ABCG2—Transmembrane transport of small molecules—GCK—gestational diabetes	0.000172	0.000655	CbGpPWpGaD
Pazopanib—LCK—B Cell Activation—FGF2—gestational diabetes	0.000171	0.000651	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—GGCT—gestational diabetes	0.00017	0.000644	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—RBP4—gestational diabetes	0.000169	0.000643	CbGpPWpGaD
Pazopanib—ABCB1—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	0.000167	0.000634	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—MBL2—gestational diabetes	0.000166	0.000632	CbGpPWpGaD
Pazopanib—FGFR2—Disease—RBP4—gestational diabetes	0.000166	0.000631	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—MBL2—gestational diabetes	0.000166	0.00063	CbGpPWpGaD
Pazopanib—LCK—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.000164	0.000623	CbGpPWpGaD
Pazopanib—KIT—Disease—RBP4—gestational diabetes	0.000163	0.00062	CbGpPWpGaD
Pazopanib—FGFR1—MAPK Signaling Pathway—TNF—gestational diabetes	0.000163	0.000619	CbGpPWpGaD
Pazopanib—LIMK2—Developmental Biology—TNF—gestational diabetes	0.000163	0.000618	CbGpPWpGaD
Pazopanib—SH2B3—Signaling Pathways—FGF2—gestational diabetes	0.000162	0.000616	CbGpPWpGaD
Pazopanib—ITK—Immune System—FGF2—gestational diabetes	0.000162	0.000614	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—GLS2—gestational diabetes	0.00016	0.000608	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling by NGF—FGF2—gestational diabetes	0.000157	0.000597	CbGpPWpGaD
Pazopanib—FGFR3—Innate Immune System—FGF2—gestational diabetes	0.000155	0.000591	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—MTNR1B—gestational diabetes	0.000155	0.000589	CbGpPWpGaD
Pazopanib—FGFR1—Disease—RBP4—gestational diabetes	0.000155	0.000588	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—RBP4—gestational diabetes	0.000154	0.000587	CbGpPWpGaD
Pazopanib—KDR—Developmental Biology—FGF2—gestational diabetes	0.000153	0.000583	CbGpPWpGaD
Pazopanib—EPHB6—Developmental Biology—TNF—gestational diabetes	0.000153	0.000581	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—RBP4—gestational diabetes	0.000151	0.000574	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—MTNR1B—gestational diabetes	0.000151	0.000574	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—LEPR—gestational diabetes	0.000151	0.000574	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—MBL2—gestational diabetes	0.000149	0.000568	CbGpPWpGaD
Pazopanib—FGFR3—Adaptive Immune System—FGF2—gestational diabetes	0.000149	0.000567	CbGpPWpGaD
Pazopanib—FGFR2—Disease—NAMPT—gestational diabetes	0.000149	0.000566	CbGpPWpGaD
Pazopanib—CYP1A2—Biological oxidations—CYP19A1—gestational diabetes	0.000149	0.000566	CbGpPWpGaD
Pazopanib—FGFR1—Developmental Biology—LEP—gestational diabetes	0.000149	0.000565	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—LEPR—gestational diabetes	0.000148	0.000563	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—GLS2—gestational diabetes	0.000148	0.000563	CbGpPWpGaD
Pazopanib—FGFR2—Disease—GCK—gestational diabetes	0.000148	0.000562	CbGpPWpGaD
Pazopanib—BMPR1B—Signaling Pathways—LEP—gestational diabetes	0.000148	0.000562	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—RBP4—gestational diabetes	0.000147	0.00056	CbGpPWpGaD
Pazopanib—FGFR1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	0.000147	0.000559	CbGpPWpGaD
Pazopanib—CYP1A2—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000147	0.000558	CbGpPWpGaD
Pazopanib—PDGFRA—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	0.000147	0.000557	CbGpPWpGaD
Pazopanib—PDGFRB—MAPK Signaling Pathway—TNF—gestational diabetes	0.000146	0.000556	CbGpPWpGaD
Pazopanib—KIT—Disease—NAMPT—gestational diabetes	0.000146	0.000556	CbGpPWpGaD
Pazopanib—LYN—Immune System—MBL2—gestational diabetes	0.000146	0.000556	CbGpPWpGaD
Pazopanib—KIT—Disease—GCK—gestational diabetes	0.000145	0.000552	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—MTNR1B—gestational diabetes	0.000144	0.000548	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	0.000143	0.000544	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—LEPR—gestational diabetes	0.000141	0.000535	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—RBP4—gestational diabetes	0.000141	0.000534	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—LEPR—gestational diabetes	0.00014	0.000533	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—RBP4—gestational diabetes	0.000139	0.000529	CbGpPWpGaD
Pazopanib—FGFR1—Disease—NAMPT—gestational diabetes	0.000139	0.000528	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—NAMPT—gestational diabetes	0.000138	0.000526	CbGpPWpGaD
Pazopanib—CYP1A2—Aryl Hydrocarbon Receptor—TNF—gestational diabetes	0.000138	0.000526	CbGpPWpGaD
Pazopanib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—gestational diabetes	0.000138	0.000526	CbGpPWpGaD
Pazopanib—FGFR1—Disease—GCK—gestational diabetes	0.000138	0.000524	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—GCK—gestational diabetes	0.000138	0.000523	CbGpPWpGaD
Pazopanib—FLT4—Signaling Pathways—LEP—gestational diabetes	0.000135	0.000514	CbGpPWpGaD
Pazopanib—LYN—Developmental Biology—LEP—gestational diabetes	0.000131	0.000497	CbGpPWpGaD
Pazopanib—FGF1—Innate Immune System—FGF2—gestational diabetes	0.000129	0.000491	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—LEPR—gestational diabetes	0.000126	0.00048	CbGpPWpGaD
Pazopanib—LCK—Signaling by NGF—FGF2—gestational diabetes	0.000126	0.000479	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—NAMPT—gestational diabetes	0.000125	0.000474	CbGpPWpGaD
Pazopanib—FGF1—Adaptive Immune System—FGF2—gestational diabetes	0.000124	0.000472	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—GCK—gestational diabetes	0.000124	0.000471	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—LEPR—gestational diabetes	0.000124	0.00047	CbGpPWpGaD
Pazopanib—LCK—Immune System—MBL2—gestational diabetes	0.00012	0.000456	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—MTNR1B—gestational diabetes	0.000119	0.000453	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—MTNR1B—gestational diabetes	0.000117	0.000445	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—RBP4—gestational diabetes	0.000116	0.000442	CbGpPWpGaD
Pazopanib—CYP3A4—Biological oxidations—CYP19A1—gestational diabetes	0.000115	0.000437	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—RBP4—gestational diabetes	0.000114	0.000434	CbGpPWpGaD
Pazopanib—CYP3A4—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000113	0.000431	CbGpPWpGaD
Pazopanib—FGFR1—Developmental Biology—FGF2—gestational diabetes	0.000113	0.000429	CbGpPWpGaD
Pazopanib—ABCB1—Allograft Rejection—TNF—gestational diabetes	0.000113	0.000428	CbGpPWpGaD
Pazopanib—BMPR1B—Signaling Pathways—FGF2—gestational diabetes	0.000112	0.000427	CbGpPWpGaD
Pazopanib—LCK—Disease—RBP4—gestational diabetes	0.000112	0.000424	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—MTNR1B—gestational diabetes	0.000111	0.000423	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—MTNR1B—gestational diabetes	0.000111	0.000422	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—RBP4—gestational diabetes	0.000108	0.000412	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—RBP4—gestational diabetes	0.000108	0.000411	CbGpPWpGaD
Pazopanib—FGFR2—Innate Immune System—FGF2—gestational diabetes	0.000107	0.000406	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—GGCT—gestational diabetes	0.000105	0.0004	CbGpPWpGaD
Pazopanib—KIT—Innate Immune System—FGF2—gestational diabetes	0.000105	0.000399	CbGpPWpGaD
Pazopanib—FLT4—Signaling Pathways—FGF2—gestational diabetes	0.000103	0.000391	CbGpPWpGaD
Pazopanib—FGFR2—Adaptive Immune System—FGF2—gestational diabetes	0.000103	0.00039	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—LEPR—gestational diabetes	0.000101	0.000386	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—LEP—gestational diabetes	0.000101	0.000384	CbGpPWpGaD
Pazopanib—KIT—Adaptive Immune System—FGF2—gestational diabetes	0.000101	0.000383	CbGpPWpGaD
Pazopanib—LCK—Disease—NAMPT—gestational diabetes	0.0001	0.00038	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—MTNR1B—gestational diabetes	9.99e-05	0.00038	CbGpPWpGaD
Pazopanib—FGFR1—Innate Immune System—FGF2—gestational diabetes	9.97e-05	0.000379	CbGpPWpGaD
Pazopanib—LCK—Disease—GCK—gestational diabetes	9.95e-05	0.000378	CbGpPWpGaD
Pazopanib—PDGFRA—Innate Immune System—FGF2—gestational diabetes	9.94e-05	0.000378	CbGpPWpGaD
Pazopanib—LYN—Developmental Biology—FGF2—gestational diabetes	9.93e-05	0.000377	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—MTNR1B—gestational diabetes	9.78e-05	0.000372	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—RBP4—gestational diabetes	9.74e-05	0.00037	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—NAMPT—gestational diabetes	9.57e-05	0.000364	CbGpPWpGaD
Pazopanib—FGFR1—Adaptive Immune System—FGF2—gestational diabetes	9.57e-05	0.000364	CbGpPWpGaD
Pazopanib—PDGFRA—Adaptive Immune System—FGF2—gestational diabetes	9.55e-05	0.000363	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—RBP4—gestational diabetes	9.54e-05	0.000362	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—GCK—gestational diabetes	9.51e-05	0.000361	CbGpPWpGaD
Pazopanib—KDR—Developmental Biology—TNF—gestational diabetes	9.34e-05	0.000355	CbGpPWpGaD
Pazopanib—ABCB1—Transmembrane transport of small molecules—GCK—gestational diabetes	9.32e-05	0.000354	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—GLS2—gestational diabetes	9.2e-05	0.00035	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—GGCT—gestational diabetes	9.17e-05	0.000348	CbGpPWpGaD
Pazopanib—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	9.12e-05	0.000346	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—FGF2—gestational diabetes	9.06e-05	0.000344	CbGpPWpGaD
Pazopanib—PDGFRB—Innate Immune System—FGF2—gestational diabetes	8.96e-05	0.00034	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—NAMPT—gestational diabetes	8.77e-05	0.000333	CbGpPWpGaD
Pazopanib—LYN—Innate Immune System—FGF2—gestational diabetes	8.77e-05	0.000333	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—GCK—gestational diabetes	8.72e-05	0.000331	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—GGCT—gestational diabetes	8.64e-05	0.000328	CbGpPWpGaD
Pazopanib—PDGFRB—Adaptive Immune System—FGF2—gestational diabetes	8.6e-05	0.000327	CbGpPWpGaD
Pazopanib—LYN—Adaptive Immune System—FGF2—gestational diabetes	8.42e-05	0.00032	CbGpPWpGaD
Pazopanib—FGFR3—Disease—FGF2—gestational diabetes	8.36e-05	0.000318	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	8.22e-05	0.000313	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—NAMPT—gestational diabetes	8.12e-05	0.000309	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—GCK—gestational diabetes	8.07e-05	0.000307	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—MTNR1B—gestational diabetes	8.02e-05	0.000305	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—GLS2—gestational diabetes	8.01e-05	0.000305	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—RBP4—gestational diabetes	7.82e-05	0.000297	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—LEP—gestational diabetes	7.71e-05	0.000293	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—FGF2—gestational diabetes	7.67e-05	0.000291	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—GLS2—gestational diabetes	7.55e-05	0.000287	CbGpPWpGaD
Pazopanib—FGF1—Immune System—FGF2—gestational diabetes	7.53e-05	0.000286	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—GGCT—gestational diabetes	7.32e-05	0.000278	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—FGF2—gestational diabetes	7.19e-05	0.000273	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—CYP19A1—gestational diabetes	6.95e-05	0.000264	CbGpPWpGaD
Pazopanib—FGF1—Disease—FGF2—gestational diabetes	6.95e-05	0.000264	CbGpPWpGaD
Pazopanib—LCK—Adaptive Immune System—FGF2—gestational diabetes	6.9e-05	0.000262	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—LEP—gestational diabetes	6.89e-05	0.000262	CbGpPWpGaD
Pazopanib—FGFR1—Developmental Biology—TNF—gestational diabetes	6.87e-05	0.000261	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—LEP—gestational diabetes	6.72e-05	0.000255	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—LEP—gestational diabetes	6.41e-05	0.000243	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—GLS2—gestational diabetes	6.4e-05	0.000243	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—CYP19A1—gestational diabetes	6.37e-05	0.000242	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—FGF2—gestational diabetes	6.23e-05	0.000237	CbGpPWpGaD
Pazopanib—KIT—Immune System—FGF2—gestational diabetes	6.12e-05	0.000232	CbGpPWpGaD
Pazopanib—LYN—Developmental Biology—TNF—gestational diabetes	6.05e-05	0.00023	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—CYP19A1—gestational diabetes	5.9e-05	0.000224	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—FGF2—gestational diabetes	5.86e-05	0.000223	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—FGF2—gestational diabetes	5.81e-05	0.000221	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—FGF2—gestational diabetes	5.79e-05	0.00022	CbGpPWpGaD
Pazopanib—FGFR2—Disease—FGF2—gestational diabetes	5.75e-05	0.000219	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	5.72e-05	0.000217	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—GGCT—gestational diabetes	5.65e-05	0.000215	CbGpPWpGaD
Pazopanib—KIT—Disease—FGF2—gestational diabetes	5.65e-05	0.000215	CbGpPWpGaD
Pazopanib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	5.55e-05	0.000211	CbGpPWpGaD
Pazopanib—FGFR1—Disease—FGF2—gestational diabetes	5.36e-05	0.000204	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—FGF2—gestational diabetes	5.35e-05	0.000203	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—LEP—gestational diabetes	5.3e-05	0.000201	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—FGF2—gestational diabetes	5.23e-05	0.000199	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—FGF2—gestational diabetes	5.22e-05	0.000198	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—LEP—gestational diabetes	5.21e-05	0.000198	CbGpPWpGaD
Pazopanib—LYN—Immune System—FGF2—gestational diabetes	5.11e-05	0.000194	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—FGF2—gestational diabetes	5.1e-05	0.000194	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—NAMPT—gestational diabetes	5.04e-05	0.000192	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—GCK—gestational diabetes	5.01e-05	0.00019	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—LEP—gestational diabetes	4.94e-05	0.000188	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—GLS2—gestational diabetes	4.94e-05	0.000188	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—LEP—gestational diabetes	4.93e-05	0.000187	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—FGF2—gestational diabetes	4.87e-05	0.000185	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—FGF2—gestational diabetes	4.82e-05	0.000183	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—LEP—gestational diabetes	4.44e-05	0.000169	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—NAMPT—gestational diabetes	4.39e-05	0.000167	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—GCK—gestational diabetes	4.36e-05	0.000166	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—LEP—gestational diabetes	4.35e-05	0.000165	CbGpPWpGaD
Pazopanib—LCK—Immune System—FGF2—gestational diabetes	4.19e-05	0.000159	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—NAMPT—gestational diabetes	4.14e-05	0.000157	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—GCK—gestational diabetes	4.11e-05	0.000156	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—FGF2—gestational diabetes	4.03e-05	0.000153	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—FGF2—gestational diabetes	3.96e-05	0.00015	CbGpPWpGaD
Pazopanib—LCK—Disease—FGF2—gestational diabetes	3.87e-05	0.000147	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—FGF2—gestational diabetes	3.75e-05	0.000143	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—FGF2—gestational diabetes	3.74e-05	0.000142	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—CYP19A1—gestational diabetes	3.66e-05	0.000139	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—LEP—gestational diabetes	3.56e-05	0.000135	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—NAMPT—gestational diabetes	3.51e-05	0.000133	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—GCK—gestational diabetes	3.48e-05	0.000132	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—FGF2—gestational diabetes	3.37e-05	0.000128	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—FGF2—gestational diabetes	3.3e-05	0.000126	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—CYP19A1—gestational diabetes	3.19e-05	0.000121	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—CYP19A1—gestational diabetes	3.01e-05	0.000114	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—FGF2—gestational diabetes	2.71e-05	0.000103	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—NAMPT—gestational diabetes	2.71e-05	0.000103	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—GCK—gestational diabetes	2.69e-05	0.000102	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—CYP19A1—gestational diabetes	2.55e-05	9.68e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CYP19A1—gestational diabetes	1.97e-05	7.47e-05	CbGpPWpGaD
